Cargando…
The Landscape of Small Leucine-Rich Proteoglycan Impact on Cancer Pathogenesis with a Focus on Biglycan and Lumican
SIMPLE SUMMARY: Cancer is a complex disease in which both cells and their environment are altered. A tumor microenvironment contains tumor cells, normal tissue cells, blood vessels, cells of the immune system, stromal cells, and the extracellular matrix (ECM). The small leucine-rich proteoglycans (S...
Autores principales: | Berdiaki, Aikaterini, Giatagana, Eirini-Maria, Tzanakakis, George, Nikitovic, Dragana |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10377491/ https://www.ncbi.nlm.nih.gov/pubmed/37509212 http://dx.doi.org/10.3390/cancers15143549 |
Ejemplares similares
-
Lumican in Carcinogenesis—Revisited
por: Giatagana, Eirini-Maria, et al.
Publicado: (2021) -
Proteoglycans in the Pathogenesis of Hormone-Dependent Cancers: Mediators and Effectors
por: Tzanakakis, George, et al.
Publicado: (2020) -
Biglycan Interacts with Type I Insulin-like Receptor (IGF-IR) Signaling Pathway to Regulate Osteosarcoma Cell Growth and Response to Chemotherapy
por: Giatagana, Eirini-Maria, et al.
Publicado: (2022) -
Lumican mediates HTB94 chondrosarcoma cell growth via an IGF-IR/Erk1/2 axis
por: Papoutsidakis, Antonis, et al.
Publicado: (2020) -
Inhibitory Role of the Small Leucine-Rich Proteoglycan Biglycan in Bladder Cancer
por: Niedworok, Christian, et al.
Publicado: (2013)